Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hak Choy

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)Gregory M M Videtic, Chen Hu, Anurag K Singh, et al.
Advances in Radiation Oncology|September 23, 2022
T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung CancerEric J Hsu, Jameson T Mendel, Kristin A Ward, et al.
JAMA Oncology|October 4, 2017
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical TrialPuneeth Iyengar, Zabi Wardak, David E Gerber, et al.
European Urology Oncology|January 6, 2022
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney CancerRaquibul Hannan, Michael Christensen, Hans Hammers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysisAlexander Sun, Kyounghwa Bae, Elizabeth M Gore, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
In reply to Zagar and MarksFeng Ming Spring Kong, Timothy Ritter, Douglas Quint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancerHak Choy, Abdenour Nabid, Baldassarre Stea, et al.
Clinical Lung Cancer|November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer CongressHeather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
Journal of the National Cancer Institute|May 28, 2010
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trialCharles Lu, J Jack Lee, Ritsuko Komaki, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)Gregory M M Videtic, Chen Hu, Anurag K Singh, et al.
Advances in Radiation Oncology|September 23, 2022
T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung CancerEric J Hsu, Jameson T Mendel, Kristin A Ward, et al.
JAMA Oncology|October 4, 2017
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical TrialPuneeth Iyengar, Zabi Wardak, David E Gerber, et al.
European Urology Oncology|January 6, 2022
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney CancerRaquibul Hannan, Michael Christensen, Hans Hammers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysisAlexander Sun, Kyounghwa Bae, Elizabeth M Gore, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
In reply to Zagar and MarksFeng Ming Spring Kong, Timothy Ritter, Douglas Quint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancerHak Choy, Abdenour Nabid, Baldassarre Stea, et al.
Clinical Lung Cancer|November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer CongressHeather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
Journal of the National Cancer Institute|May 28, 2010
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trialCharles Lu, J Jack Lee, Ritsuko Komaki, et al.
Pageof 14